Subscribe
shutterstock_1513301072_bernsten-1
shutterstock_1513301072_bernsten
23 June 2022Sarah Speight

WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

After several days and sleepless nights, members of the World Trade Organisation (WTO) finally agreed several key trade initiatives last week, including one that promises to suspend patent protection of the COVID-19 vaccines.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
US supports delay to COVID waiver extension
8 December 2022   Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about the controversial patent waiver.
Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.
Big Pharma
Governments may have to reserve 20% of vaccines: WHO
2 February 2023   Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
US supports delay to COVID waiver extension
8 December 2022   Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about the controversial patent waiver.
Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.
Big Pharma
Governments may have to reserve 20% of vaccines: WHO
2 February 2023   Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.

More on this story

Americas
US supports delay to COVID waiver extension
8 December 2022   Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about the controversial patent waiver.
Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.
Big Pharma
Governments may have to reserve 20% of vaccines: WHO
2 February 2023   Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.

More features

Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Pfizer, Moderna vow appeals after split vaccine ruling
Unified Patent Court: The cases, the numbers and what the future holds
Second chances: Brazil’s bid to revitalise the country’s healthcare system
Why the US non-competes ban has riled Big Pharma
Life sciences cases at the UPC will surely rise, but is the court prepared?
WIPO adopts first-of-its-kind treaty on genetic resources and traditional knowledge
HDT Bio and Emcure resolve $950m trade secrets 'misunderstanding'